THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS VIRAL LOAD SUPPRESSION ON ART IN VIETNAM Speaker: Le Truong Giang PhD, MD President of HCMC Association.

Slides:



Advertisements
Similar presentations
A Training Needs Analysis of Health Workforce Competencies in HIV Care and Treatment Services in Rwanda (L305) Presented by: Dr. Peter Memiah Presented.
Advertisements

Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
FACTORS HINDERING ATTITUDE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN THE NIGER DELTA, NIGERIA by AGOFURE OTOVWE and OYEWOLE OYEDIRAN.
Syphilis and HIV screening initiatives in North Carolina jails Lynne A. Sampson PhD, MPH HIV/STD Update September 25, 2008.
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
Fast-track to ending AIDS in Zimbabwe: opportunities
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
Validating five questions of antiretroviral non-adherence in a decentralized public-sector antiretroviral treatment program in rural South Africa Krisda.
Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,
Use and acceptability of biomedical HIV prevention technologies among MSM and MSW in Vietnam Donn Colby, MD, MPH Harvard Medical School AIDS Initiative.
Involving the Community in HIV/AIDS Treatment Support Programmes: An Evidence-Based Approach.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Baseline Antiretroviral Resistance Testing among HIV-Positive Injection Drug Users in a Canadian Setting Nadia Fairbairn 1 M-J Milloy 1 Thomas Kerr 1,
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK.
Transition Program of HIV-infected adolescents to Adult HIV care in Buenos Aires, Argentina S. Arazi Caillaud 1, D. Mecikovsky 1, A.Bordato.
Management and Development for Health (MDH)
Generously supported by the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Veteran Affairs, and National Institutes of Health,
Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.
INTRODUCTION Evaluation of Outcomes in Patients Starting Antiretroviral Therapy During Hospitalization Leigh E. Efird, PharmD 1, Manish Patel, PharmD 1,
M. Ekstrand 1,2,3, A. Shet 2,4, S. Chandy 4, G. Singh 4, R. Shamsundar 4, V. Madhavan 5, S. Saravanan 5, N. Kumarasamy 5 1 University of California, San.
The Positive Predictive Value of World Health Organization (WHO) Immunologic Criteria for Treatment Failure in a Public Health Antiretroviral Delivery.
Arnold School of Public Health Health Services, Policy, and Management 1 Drug Treatment Disparities Among African Americans Living with HIV/AIDS Carleen.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.
Good Three-year Outcomes of Antiretroviral Therapy at Multiple NGO- assisted facilities in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
1 The impact of ongoing illicit drug use on virologic suppression in HIV-infected injection drug users receiving HAART Authors: Harout Tossonian, Jesse.
TRENDS OF HIV PREVALENCE, NEEDLE SHARING, AND EXPOSURE TO HIV/AIDS INTERVENTION AMONG PWID IN VIETNAM: IBBS RESULTS Nguyen Anh Tuan NATIONAL INSTITUTE.
Predicting Pregnancy Risk among Women Attending an STD Clinic Judith Shlay MD, MSPH Denver Public Health September 21, 2008 CityMatCH Conference.
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
Prevalence and risk factors for self-reported sexually transmitted infections among adults in the Diepsloot informal settlement, Johannesburg, South Africa.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
The 6 th National Scientific Conference on HIV/AIDS BASIC INTERVENTION PACKAGE FOR PEOPLE WHO INJECT DRUG: COVERAGE AND IMPACT ON RISK BEHAVIORSCOVERAGE.
Factors associated with concurrent Heroin use among patients on Methadone maintenance treatment in Vietnam from 2008 to 2013 Hoang Nam Thai MD, MPH – CDC/DGHT.
World Health Organization | Viet Nam Country Office1 Enhancing Benefits of Early Antiretroviral Therapy Evidence, Implication and Preliminary Findings.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Late maternal HIV testing, HCMC Chi K. Nguyen 1, Haily T. Pham 2, ThuVan T. Tieu 2, Chinh.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS The acquired HIV drug resistance among HIV adults receiving ART at least 36 months in Vietnam Vũ Quốc.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Evaluation of two techniques for viral load monitoring on DBS ANRS project Phase I - Laboratory.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS KNOWLEDGE ABOUT HIV/AIDS, AMONG HEALTH WORKERS IN THREE PROVINCES IN NORTHERN VIETNAM: A CROSS-SECTIONAL.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS THE INITIAL RESULTS OF INTEGRATED ARV-MMT IN PREVENTIVE MEDICINE CENTERS IN HCMC Tieu Thi Thu Van,
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Study on Transgender Women’s Health and Well-being in Ho Chi Minh City, Vietnam (TransVN Study) Le.
Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
The Impact of Darunavir/ritonavir (DRV/r) & Raltegravir (RAL) in the Clinic: A New Era for Treatment-Experienced Patients? M. Mugavero 1, H. Lin 1, J.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS H HIV Prevention for Female Sexual Partners of People Who Inject Drugs: Evaluation Results Theodore.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Dropout and return rate in methadone maintenance treatment program in Thai Nguyen from 30/9/2011 to.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System Predictors for high viraemia among the treatment naïve population.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
1 Predictors of virological failure in a Cambodian setting Sokkab An, M.D Sihanouk Hospital Center of HOPE (SHCH), Phnom Penh, Cambodia.
HIV Drug Resistance Surveillance Satellite Session: HIV Drug Resistance Surveillance and Control: a Global Concern Silvia Bertagnolio, MD WHO,
Center for Studies of Addiction, University of Pennsylvania, USA
Kimberly Green Regional Technical Advisor FHI Viet Nam/APRO
High HIV prevalence among drug injecting female sex workers in Viet Nam: The need to reduce both sexual and injection risks in this vulnerable population.
Factors affecting virological failure in patients receiving antiretroviral therapy: a prospective HIV Clinical cohort in rural Uganda. Patrick Kazooba1,
NYSDOH AIDS Institute Quality of Care Program eHIVQUAL
Utilizing research as an opportunity to strengthen
San Francisco Department of Public Health
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Management and Development for Health (MDH)
Public Health Implications
Presentation transcript:

THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS VIRAL LOAD SUPPRESSION ON ART IN VIETNAM Speaker: Le Truong Giang PhD, MD President of HCMC Association of Public Health

The 6 th National Scientific Conference on HIV/AIDS This study received financial support from U.S. Agency for International Development (USAID) under its SMART TA / FHI 360 project This study was done by Suresh Rangarajan, Lê Trường Giang, Nguyên Hữu Hưng, Donn Colby, Tou Plui Brơh, Trần Trí Danh, Trần Ngọc Bảo Châu, Nguyễn Đức Anh, Hoàng Nguyễn Bảo Trâm, Đoàn Vũ Tuyết Nga, Nguyễn Nhật Quang, Phạm Văn Phước, Đào Đức Giang, Mario Chen, Yanwu Zeng, Bùi Đúc Dương, Tiêu Thị Thu Vân, Trần Mỹ Hạnh, Lê Thị Hoa, Hoàng Xuân Chiến, Gary West

The 6 th National Scientific Conference on HIV/AIDS Outline 1.Background 2.Objectives 3.Methods 4.Results 5.Discussions 6.Conclusions & recommendations

The 6 th National Scientific Conference on HIV/AIDS Background The goal of early antiretroviral treatment (ART) for patients with HIV infection:  to completely suppress viral replication, thus  preventing further damage to the immune system,  decreasing AID associated morbidity and mortality,  allowing immune function to return to normal, and reducing the risk of transmitting HIV infection to others The rate of viral suppression among patients on ART across Vietnam is not known because routine laboratory monitoring of HIV viral load is not performed in the public treatment program.

The 6 th National Scientific Conference on HIV/AIDS 2020 Targets 90% of all people living with HIV will know their HIV status 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy 90% of all people receiving antiretroviral therapy will have viral suppression.

The 6 th National Scientific Conference on HIV/AIDS Objectives The primary purpose of the study was to determine the rate of HIV virological suppression among Vietnamese patients on antiretroviral treatment (ART) for at least one year. Secondary objectives: to identify potential factors associated with unsuppressed viral loads including time on demographic characteristics of patients, geographic location, donor (PEPFAR vs. Global Fund), adherence measures, MMT versus non-MMT injection drug users…

The 6 th National Scientific Conference on HIV/AIDS Methods 12 OPCs in HCMC, An Giang, Quảng Ninh and Dien Bien Year 2014 The assessment is cross-sectional in design. Inclusion criteria were age >18 years, on ART for more than one year, and return to clinic for a regular follow-up visit. Patients were randomly sampled from the total eligible population of patients on ART > 1 year.

The 6 th National Scientific Conference on HIV/AIDS Patients enrolled 1,261 patients enrolled –2 subjects excluded due to lack of viral load data –4 subjects excluded for on-treatment <12 months 1,255 patients included in analysis population –201 (16%) An Giang –200 (16%) Dien Bien –655 (52%) HCMC –199 (16%) Quang Ninh 361 patients included in sub-analysis population of PWID on MMT versus not on MMT in five integrated 3:1 clinics (Tuan Giao, D8, D6, Thu Duc, Binh Thanh)

The 6 th National Scientific Conference on HIV/AIDS Methods During each study visit, consented participants completed a structured survey questionnaire administered by clinic staff After completing the questionnaire, patients underwent routine follow-up and blood work with the addition of a single viral load test. Plasma viral load samples => 1,000 copies/ml had an additional genotype test. Samples were transported to:  National Institute of Hygiene and Epidemiology (NIHE) in Ha Noi  Pasteur Institute (PI) in HCMC

The 6 th National Scientific Conference on HIV/AIDS Methods The study was approved by: 1.Research Ethical Committee of the Ha Noi School of Public Health 2.FHI 360 Office of International Research Ethics, Protection of Human Subjects Committee. All data was coded by a unique identifier to maintain participant confidentiality.

The 6 th National Scientific Conference on HIV/AIDS Methods Data analysis Descriptive statistics (e.g., frequencies for categorical variables and mean, standard deviation, median, range, IQR for continuous variables) are provided for relevant variables in the study database. Based on primary data collected a number of new variables were created to better characterize the analysis population.

The 6 th National Scientific Conference on HIV/AIDS Methods Data analysis Alcohol and drug use were assessed for the previous 30 days. Major Depression was defined as having a total CES-D Score =>16. High Stigma was defined as a stigma score >=5 based on responses to individual questions. Clinical variables included both patient report and data extracted from the medical record.

The 6 th National Scientific Conference on HIV/AIDS Methods Data analysis Viral Suppression is defined as having a documented HIV viral load on day of study visit of less than 1000 cps/ml. Descriptive statistics and sensitivity analysis under different viral load thresholds for suppression are also provided for viral load suppression thresholds <250 cps/ml and <500 cps/ml versus 1000 cps/ml in a separate analysis.

The 6 th National Scientific Conference on HIV/AIDS Methods Data analysis Bivariate analyses were conducted on the entire analysis population to assess the associations of biological markers and demographical and behavioral characteristics with HIV viral suppression (< or ≥1,000 cps/ml). For testing the association with other categorical variables, use Chi-square tests. For comparing continuous variables between the HIV RNA viral load groups, use t-tests or ANOVA tests. A trend analysis examining the relationship between viral suppression and “Category Time Year on ART” using Cochrane Armitage trend test.

The 6 th National Scientific Conference on HIV/AIDS Methods Data analysis A multivariate analysis was conducted to assess adjusted associations between selected variables and viral suppression. A logistic regression model was used for examining the dichotomous viral load suppression variable to identify factors associated with viral suppression. The results of the descriptive and the bivariate analysis were used to select an initial set of variables to be included in the multivariate model.

The 6 th National Scientific Conference on HIV/AIDS Results Demographic characteristics of OPC patients on ART > 1 year (n = 1,255) The median age was 34.5 years (range 18-74). The majority was male (66%), married (63%), and employed (76%). Median time on ART was 46 months (IQR 28 – 70 months). The most common ARV regimen was TDF/3TC/EFV (52%)

The 6 th National Scientific Conference on HIV/AIDS Viral Suppression Rates Province * Bivariate analysis (p-value threshold of <0.05 for significance). p = 0.09 Overall viral suppression as defined as a HIV viral load <1000 cps/ml was 93% (95% CI 91.7 – 94.5%).

The 6 th National Scientific Conference on HIV/AIDS Viral Suppression Rates at Different Viral Load Thresholds UNAIDS Target by 2020

The 6 th National Scientific Conference on HIV/AIDS Viral Suppression Rates Age and Gender p = 0.04p = NS *Bivariate analysis (p-value threshold of <0.05 for significance).

The 6 th National Scientific Conference on HIV/AIDS Results Clinical characteristics and bivariate analysis with HIV Viral Load (VL) Median CD4 cell count was 443 cells/mm 3 (IQR 297 – 613). Median baseline CD4 count was 136 cells/mm 3 ( ). CD4 while on ART was an increase 3 folds. 1/5 of study participants had two or more late appointments in the past year and 6 % had treatment interruptions for more than one week in the past year

The 6 th National Scientific Conference on HIV/AIDS Viral Suppression Rates Adherence Measures p = NSp < *Bivariate analysis (p-value threshold of <0.05 for significance). p = NS p = 0.02

The 6 th National Scientific Conference on HIV/AIDS Results Multivariate analysis of factors associated with virological failure Based on multivariate analysis, factors independently associated with HIV viral load => 1,000 copies/ml were: Lower baseline CD4 (p<0.0001) Social isolation (p=0.0328) HIV stigma (p=0.0524) Multiple late appointments in the previous year (p=0.0018) Not on a single-tablet regimen (p=0.0003) High internalized HIV stigma (p=0.0103) Immunological treatment failure (p=0.0018)

The 6 th National Scientific Conference on HIV/AIDS Viral Suppression Rates PWID and MMT p = 0.02p = NS *Bivariate analysis (p-value threshold of <0.05 for significance). MMT did not have a significant impact on suppression rates.

The 6 th National Scientific Conference on HIV/AIDS Discussions Viral load suppression in the four provinces was 93% (88% - 100%). This high rate of suppression already exceeds the UNAIDS target. Viral suppression is measured as on-treatment rates and does not take into account patients not enrolled in care, loss to follow-up or who have died.

The 6 th National Scientific Conference on HIV/AIDS Discussions On treatment viral suppression rates represents:  A high level of adherence of those enrolled in care  Potent ART regimens - particularly a once daily single tablet regimen (EFV-3TC-TDF)  Limited exposure to dual ARV therapy  Low-levels of transmitted drug resistance Adherence assessment by recording in patient charts (>95% or <95%) or VAS is not valuable for predicting viral load suppression. A number of simpler measures such as reporting number of late appointment or number of days quit of ART.

The 6 th National Scientific Conference on HIV/AIDS Conclusion and recommendations ART is durable with ongoing suppression of viral loads overtime Routine viral loads for all patients on ART at 12 months: improved access to viral load testing is critical to ending the HIV epidemic. HIV programs should proactively switch patients to the EFV-3TC-TDF STR regimen

The 6 th National Scientific Conference on HIV/AIDS Conclusion and recommendations Social isolation and fear of disclosure must be addressed among all PLHIV Streamline and target intensive adherence screening to patients in most need Expansion of mobile technologies, treatment buddies, and community base support for PLHIV on ART

The 6 th National Scientific Conference on HIV/AIDS Acknowledge We would like to give sincerely thanks to: All the study patients and their family USAID to provide financial support for this study Abbott Molecular Company to support Viral load test kids for patients in Quang Ninh and Dien Bien 4 PACs and 12 OPCs staff of Quang Ninh, Dien Bien, An Giang and HCMC